Medical Device News Magazine

Sharp Fluidics Clinical Study, Efficacy of a Novel Intraoperative Engineered Sharps Injury Prevention Device: Pilot Usability and Efficacy Trial, Published in JMIR Perioperative Medicine

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

December 22, 2020

Sharp Fluidics reports the first prospective, case-controlled clinical study of an Engineered Sharps Injury Prevention (ESIP) device to prevent Needle Stick Injuries (NSI) in an operating room demonstrated that the use of Operative Armour®, a wearable needle safety and workflow efficiency device, reduces surgical needle passes and handling during surgical closure.

This study, “Efficacy of a Novel Intraoperative Engineered Sharps Injury Prevention Device: Pilot Usability and Efficacy Trial,” Jenny Hillary, M.D., et al. conducted at The Johns Hopkins University School of Medicine, was published in JMIR Perioperative Medicine.

In the 100-patient study, 50 procedures were performed using Operative Armour and 50 control procedures without.  The procedures performed were in Plastics Surgery including abdominal surgery, breast reconstruction, and mastopexy/breast reduction or revisions.  During these procedures, Operative Armour resulted in as many as half the needle adjustments by hand.

“In this study at Johns Hopkins it was found that Operative Armour functions effectively as an engineered Sharps Injury Prevention device by decreasing intraoperative needle passing and handling”, said Douglas Rimer, President of Sharp Fluidics.  “The authors stated, ‘By minimizing sharps behaviors that drive needle stick injuries such as manipulation, handling, and passing of intraoperative sharps, Operative Armour demonstrates superiority over the current practice in the potential to significantly decrease sharp injuries.  We anticipate an associated decrease in needlestick injuries with the use of the device.'”

Other observations by the authors included the potential for OR efficiency gains, “In addition to the device’s impact on needlestick risk, it may also have the potential to improve efficiency by introducing parallel processing in which two or more separate processes are conducted simultaneously rather than in series.” While the surgeon is closing independently, managing their own sutures, the circulator and scrub-tech can focus on performing their final count and breaking down the room, eliminating conflict between these two equally important activities.

The study concluded that Operative Armour effectively functions as an ESIP device by decreasing intraoperative needle passing and handling.  With over 88,000 operating room needlestick injuries in the US each year, Operative Armour provides a new option to help keep Surgeons, Nurses, and other medical staff safer in the operating room.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”